Hans-Peter Rudolf

Hans-Peter Rudolf

Directeur/Membre du Conseil chez
Phosphate Therapeutics Ltd.
60 ans
Commercial Services
Consumer Services
Health Technology

Profil

Hans-Peter Rudolf is currently a Director at Phosphate Therapeutics Ltd. He previously worked as an Audit Partner at Ernst & Young LLP from 2003 to 2006, and as a Partner at Ernst & Young AG.
He was also the Head-Group Accounting at Bellefontaine Investments AG from 2011 to 2017, and an Audit Partner at Crowe LLP from 2006 to 2010.
From 2017 to 2020, he served as the Chief Financial Officer at Vicarius Pharma AG.
Rudolf holds an undergraduate degree from Cleveland State University and the University of Zurich.
He is currently the Chief Financial Officer at Shield Therapeutics Plc.

Postes actifs de Hans-Peter Rudolf

SociétésPosteDébut
Directeur/Membre du Conseil 12/05/2021

Anciens postes connus de Hans-Peter Rudolf

SociétésPosteFin
SHIELD THERAPEUTICS PLC Directeur Financier/CFO 20/10/2023
Directeur Financier/CFO 01/04/2020
Comptroller/Controller/Auditor 01/04/2017
Corporate Officer/Principal 01/12/2010
Corporate Officer/Principal 01/07/2006
Voir l'expérience en détail de Hans-Peter Rudolf

Formation de Hans-Peter Rudolf

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

84

Relations au 1er degré

9

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées9

Commercial Services

Consumer Services

Consumer Services

Commercial Services

Finance

Commercial Services

Health Technology

Health Technology

Commercial Services

  1. Bourse
  2. Insiders
  3. Hans-Peter Rudolf